Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01752166 · ClinicalTrials.gov registry record
Detecting Infections Rapidly and Easily for Candidemia Trial - Part 2 (direcT2 Study)
A clinical trial, sponsored by T2 Biosystems.
- Completed
- Registry status
- 1,500
- Enrollment target
NCT01752166 is a clinical trial that has completed, run by T2 Biosystems. The registered enrollment target is 1,500 participants.
The verdict
NCT01752166 has completed, sponsored by T2 Biosystems.
- COMPLETED
- Registry status
- 1,500 participants
- Enrollment target
Study Summary
The purpose of this study is to validate clinical performance (i.e. estimated sensitivity and specificity) of the T2 Candida test on the T2 DX Instrument compared to blood culture results and/or known Candida positive status of prospectively collected and contrived (i.e. Candida-spiked) clinical specimens.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01752166
The ClinicalTrials.gov registry entry for NCT01752166 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is T2 Biosystems, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01752166 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01752166 about?
NCT01752166 is a clinical study titled "Detecting Infections Rapidly and Easily for Candidemia Trial - Part 2 (direcT2 Study)". The purpose of this study is to validate clinical performance (i.e. estimated sensitivity and specificity) of the T2 Candida test on the T2 DX Instrument compared to blood culture results and/or known Candida positive status of prospectively collected and contrived (i.e. Candida-spiked) clinical spe...
What is the current status of trial NCT01752166?
This trial is currently completed. The enrollment target is 1,500 participants. The study started on 2013-07. Estimated completion is 2014-04.
Who is sponsoring clinical trial NCT01752166?
This trial is sponsored by T2 Biosystems, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.